NASDAQConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for WVVI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain positive cash from operations above $700k | Cash from operations improved to positive $794,947 in 2026-Q1. | Improving | cash from operations falls below $700,000 next 4 quarters | Cash from operations: $1.95M FY2026-Q2; GAAP. Published target: cash from operations >= $700,000 next 4 quarters. Target period is not explicitly aligned with this observation. Aug 12, 20261,950,452 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business with a weak recent financial record, not a proven durable compounder. Its thesis state is watch, and the signal has recently shifted from cautious to mixed.
The valuation evidence points to WVVI being cheap versus peers, while the expectations gap is small. The model has low confidence, and the evidence does not show that the relative discount alone resolves the company’s weak results.
Over the near term, revenue and operating income trends remain weak: both declined between 2024-Q4 and 2026-Q2, despite management emphasizing improvement across the last eight quarters. Operating cash flow improved over that period, but limited progress on profitability and sales growth remains a key concern for the multi-year view.
The thesis depends on whether management can turn better cash generation into stronger sales and operating profitability. Near-term sector signals matter too: continued earnings strength from bellwethers could sustain a sector tailwind, while weaker employment data or bellweller misses could weigh on cyclical businesses like WVVI.
For the next 1 to 3 years, WVVI has a mixed setup: cash generation has improved, but core sales and profitability trends have deteriorated, and the evidence for a durable recovery is limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 8 of last 8 quarters. Cash from operating activities improved from -$1,077,915 in 2024-Q4 to $1,950,452 in 2026-Q2, showing a positive trend. Management's repeated focus on cash flow and operating cash generation is reflected in this improving trajectory.
Maintain stable leadership with new CFO | New CFO appointment supports leadership stability. | Intact | unexpected CFO or key leadership departures | 0 departures vs 0 allowed John Hazlett appointed CFO in May 2026 to replace retiring John Ferry. No subsequent executive departures reported. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce operating losses toward break-even | A primary condition in Willamette Valley Vineyards Inc's published investment case. The stated target is operating income trending toward zero or positive next 4 quarters. | Under Pressure | operating income remains negative and worsens next 4 quarters | Operating income: $-1.354M FY2026-Q2; GAAP. Published target: operating income trending toward zero or positive next 4 quarters. Target period is not explicitly aligned with this observation. Aug 12, 2026-1,353,969 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 8 of last 8 quarters. Operating income declined from $774,035 in 2024-Q4 to -$1,353,969 in 2026-Q2, showing a worsening trend. Despite consistent emphasis, the financial trajectory is declining, indicating limited progress on improving operating income and profitability. Delivery assessment Oct 12, 2026 |
Sustain or grow revenue above $8 million next 4 quarters | A primary condition in Willamette Valley Vineyards Inc's published investment case. The stated target is >= $8 million total revenue next 4 quarters. | Under Pressure | total revenue falls below $8 million next 4 quarters | Revenue: $10.036M FY2026-Q2; GAAP. Published target: >= $8 million total revenue next 4 quarters. Target period is not explicitly aligned with this observation. Aug 12, 202610,036,275 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 8 of last 8 quarters. Revenue declined from $11,276,291 in 2024-Q4 to $10,036,275 in 2026-Q2, indicating a negative trend. Despite repeated emphasis on sales growth, the revenue trajectory is declining, showing limited progress on this priority. Delivery assessment Oct 12, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.